Expiratory Muscle Strength training (EMST) versus traditional dysphagia rehabilitation for intervention of dysphagia in Parkinson’s disease in the community setting.

Not Applicable

Completed

• Conditions: Dysphagia; Parkinson's disease; Physical Medicine / Rehabilitation - Speech therapy; Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12618000090213
• Lead Sponsor: orthern Health Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-01-19
• Study Completion: 2018-12-03
• Last Update Posted: 28 January 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 23

Inclusion Criteria

Have a formal diagnosis of idiopathic Parkinson’s disease
-Able to provide informed consent. Consent may also be provided by a person who has legal authority to do so (e.g. carer, Next of Kin).
-Report some degree of swallowing impairment (e.g. reports coughing during eating a and drinking, food getting stuck in throat, increased eating duration)
-Age between 55 and 88
-Mini Mental Score > 24 or Mini Mental Score 22-23 with carer support.
-Preference for the participant to remain on the same Parkinson’s disease medications for the duration of the study
-Nil residual deficits from other neurological disorders, gastrointestinal disease, gastro-oesophageal surgery, head and neck cancer, history of respiratory disorders, untreated hypertension or heart disease
It is the preference of the researchers that participants will not change their medications relating to PD during the research trial as this may influence results. However, if this is necessary, participants will be asked to inform the researchers of any changes. They are also restricted from participating in any other Speech Pathology rehabilitative treatment during the study.

Exclusion Criteria

- MMSE < 24 and unable to complete daily home practice regime due to cognition/ nil carer support
- residual deficits from other neurological disorders, gastrointestinal disease, gastro-oesophageal surgery, head and neck cancer, history of respiratory disorders, untreated hypertension or heart disease
- nil dysphagia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in swallow function pre/post intervention will be identified by the primary outcome measure the Modified Barium Swallow Impairment Profile (MBSimp) which provides overall scores for oral and swallow function. The MBSimp will be completed pre/post the six week intervention programs via scoring of the pre/post Videofluoroscopy Swallowing Study (VFSS). Each participant will then attend a pre intervention and post intervention swallow X-ray (videofluoroscopic swallowing study) approximately one hour after taking their Parkinson’s disease medication.<br>The MBSimp will be completed pre and post a swallow x-ray (Videofluoroscopy Swallow Study). The clinician completing the MBSimp will be blinded to treatment group.[The pre-VFSS is completed before the 6 week intervention period is commenced and the post-VFSS is completed when the 6 week of intervention have been completed.]